OTHERClinicalTrials.gov【Trial record】
A Post Approval Study to Evaluate Safety and Effectiveness of Multicompartmental Dosimetry Planning.
Not yet recruitingSource updated: Oct 1, 2026
Cancer types
Liver Cancer
Incl. hepatocellular carcinoma (HCC). 94 official records currently indexed across three regions.
Trial records retrieved live from the ClinicalTrials.gov public API.
Showing 94 of 94
Highlight terms:
Build a discussion list0 selected
Select the public official records you want to take to your appointment, then generate a list. Nothing is ranked or recommended — the list only reproduces titles and links.
Not signed in — up to 5 records per list. Sign in for higher free limits, or see Pro for more exports.
OTHERClinicalTrials.gov【Trial record】
A Study to Evaluate the Pharmacokinetics and Safety of INCB161734 in Participants With Hepatic Impairment
Phase 1Not yet recruitingSource updated: Oct 1, 2026
CNClinicalTrials.gov【Trial record】
Atezolizumab and Bevacizumab With Photon Radiotherapy for Unresectable Hepatocellular Carcinoma
Phase 2RecruitingSource updated: Oct 1, 2026
USClinicalTrials.gov【Trial record】
Comparative Autoantibody and Immunologic Cell Marker Study
Enrolling by invitationSource updated: Oct 1, 2026
CNClinicalTrials.gov【Trial record】
Evaluation of Immune Responses and Outcomes in Patients With Hepatocellular Carcinoma Undergoing Radiotherapy
RecruitingSource updated: Oct 1, 2026
USClinicalTrials.gov【Trial record】
Hepatic Artery Infusion of Carfilzomib in Participants With Liver Metastatic Disease Previously Treated With Hepatic Artery Infusion Pump Therapy
Phase 1Not yet recruitingSource updated: Oct 1, 2026
CNClinicalTrials.gov【Trial record】
Individualized Comprehensive Treatment for Advanced Hepatocellular Carcinoma
Not applicableRecruitingSource updated: Oct 1, 2026
USClinicalTrials.gov【Trial record】
PDS01ADC in Combination With Hepatic Artery Infusion Pump (HAIP) and Systemic Therapy for Subjects With Metastatic Colorectal Cancer, Intrahepatic Cholangiocarcinoma, or Metastatic Adrenocortical Carcinoma
Phase 2RecruitingSource updated: Oct 1, 2026
CNClinicalTrials.gov【Trial record】
Photon Radiotherapy Plus Tremelimumab/Durvalumab for BCLC Stage B and C HCC
Phase 2RecruitingSource updated: Oct 1, 2026
CNClinicalTrials.gov【Trial record】
Proton Radiotherapy Plus Tremelimumab/Durvalumab for BCLC Stage B and C HCC
Phase 2RecruitingSource updated: Oct 1, 2026
CNClinicalTrials.gov【Trial record】
PULSAR Combined With PD-1 Ab and Chemotherapy Plus Bev. for CRLM
Phase 2RecruitingSource updated: Oct 1, 2026
USEUOTHERClinicalTrials.gov【Trial record】
Study of Cabozantinib Alone or in Combination With Atezolizumab to Subjects With Locally Advanced or Metastatic Solid Tumors
Phase 1Active, not recruitingSource updated: Oct 1, 2026
USEUOTHERClinicalTrials.gov【Trial record】
Study of Zanzalintinib in Combination With Immuno-Oncology or Other Agents in Participants With Solid Tumors
Phase 1RecruitingSource updated: Oct 1, 2026
USOTHERClinicalTrials.gov【Trial record】
Targeted Therapy Directed by Genetic Testing in Treating Patients With Advanced Refractory Solid Tumors, Lymphomas, or Multiple Myeloma (The MATCH Screening Trial)
Phase 2Active, not recruitingSource updated: Oct 1, 2026
USEUClinicalTrials.gov【Trial record】
TheraSphere With Durvalumab and Tremelimumab for HCC
Phase 2Active, not recruitingSource updated: Oct 1, 2026
CNClinicalTrials.gov【Trial record】
A Prospective Real-World Observational Study of Intratumoral Oncolytic Virus Injection Combined With Immune Checkpoint Inhibitors for Metastatic Tumors (Colorectal Cancer, Gastric Cancer, and Hepatocellular Carcinoma)
RecruitingSource updated: Sep 30, 2026
CNClinicalTrials.gov【Trial record】
InstaSure™ Non-Invasive Finger-Press Test for Hepatocellular Carcinoma
RecruitingSource updated: Sep 30, 2026
CNClinicalTrials.gov【Trial record】
NK521 in the Treatment of Advanced Solid Tumors
Early Phase 1Not yet recruitingSource updated: Sep 30, 2026
USClinicalTrials.gov【Trial record】
Real-World Lenvatinib Sequencing in Unresectable Hepatocellular Carcinoma (uHCC)
Active, not recruitingSource updated: Sep 30, 2026
USClinicalTrials.gov【Trial record】
SAMe in Prevention of Oxaliplatin-associated Liver Injury
Phase 2Not yet recruitingSource updated: Sep 30, 2026
USClinicalTrials.gov【Trial record】
The Cancer Connected Access and Remote Expertise Beyond Walls Program to Provide In-Home Cancer Treatment and Improve Treatment Satisfaction in Cancer Patients Living in the Florida Panhandle and Surrounding Areas
Phase 2RecruitingSource updated: Sep 30, 2026
CNClinicalTrials.gov【Trial record】
Cryoablation Combined With Hepatic Arterial Infusion of Iparomlimab and Tuvonralimab (QL1706), Intravenous Dacarbazine, and Oral Lenvatinib in Patients With Liver Metastases From Malignant Melanoma: a Single-arm, Phase II, Prospective Trial
Phase 2RecruitingSource updated: Sep 29, 2026
CNClinicalTrials.gov【Trial record】
Fecal Microbiota Transplantation With QL1706 Plus Bevacizumab for Advanced HCC
Phase 2Not yet recruitingSource updated: Sep 29, 2026
USClinicalTrials.gov【Trial record】
Hepatic Artery Infusion Pump Chemotherapy for Liver Metastases From Resected Pancreatic and Duodenal Adenocarcinoma
RecruitingSource updated: Sep 29, 2026
USClinicalTrials.gov【Trial record】
Hepzato Kit and Opdualag for Metastatic Melanoma and Liver Metastasis
Phase 1/2RecruitingSource updated: Sep 29, 2026
CNClinicalTrials.gov【Trial record】
Hyperpolarized 13C-MRI in Patients With Hepatocellular Carcinoma Undergoing Radiotherapy, Atezolizumab, and Bevacizumab
Phase 2RecruitingSource updated: Sep 29, 2026
EUClinicalTrials.gov【Trial record】
MONTEROSA - Italian Multicenter Observational Study to Evaluate Time to Clinical Hepatic Decompensation, Quality of Life, Effectiveness, and Safety of Tremelimumab Plus Durvalumab in Patients With Advanced or Unresectable Hepatocellular Carcinoma Who Have Received no Prior Systemic Treatment.
RecruitingSource updated: Sep 29, 2026
USClinicalTrials.gov【Trial record】
Testing the Combination of Pevonedistat With Chemotherapy for Bile Duct Cancer of the Liver
Phase 2Active, not recruitingSource updated: Sep 29, 2026
CNClinicalTrials.gov【Trial record】
A Study of TACE in Combination With SHR-8068, Adebrelimab, and Bevacizumab Versus TACE in Participants With Incurable Hepatocellular Carcinoma
Phase 3Not yet recruitingSource updated: Sep 28, 2026
USClinicalTrials.gov【Trial record】
Collection of Blood From Patients With Cancer
RecruitingSource updated: Sep 28, 2026
OTHERClinicalTrials.gov【Trial record】
Comprehensive Genomic Profiling of Colorectal Cancer Patients With Isolated Liver Metastases to Understand Response & Resistance to Cancer Therapy
Active, not recruitingSource updated: Sep 28, 2026
CNClinicalTrials.gov【Trial record】
Downstaging Unresectable Hepatocellular Carcinoma to Resectable Disease With Combined Immunotherapy and Stereotactic Beamed Radiotherapy: a Pilot Study
Not applicableRecruitingSource updated: Sep 28, 2026
USClinicalTrials.gov【Trial record】
Study of the Theranostic Pair RYZ811 (Diagnostic) and RYZ801 (Therapeutic) to Identify and Treat Subjects With GPC3+ (Glypican-3) Unresectable HCC
Phase 1/2RecruitingSource updated: Sep 28, 2026
USCNOTHERClinicalTrials.gov【Trial record】
Symbiotic-GI-13: A Study to Learn About Study Medicine Called PF-08634404 as a Single Treatment and Combination Treatment in Adult Participants With a Liver Cancer Called Hepatocellular Carcinoma, That is Too Advanced to be Removed by Surgery and May Have Spread to Other Parts of the Body.
Phase 1/2RecruitingSource updated: Sep 28, 2026
USClinicalTrials.gov【Trial record】
CCR5 Targeting Leronlimab in Combination With Hepatic Arterial Infusion Floxuridine and Systemic Therapy for the Treatment of Colorectal Cancer Liver Metastases, CHAMP Trial
Phase 1Not yet recruitingSource updated: Sep 25, 2026
CNClinicalTrials.gov【Trial record】
HAI or IV of Adebrelimab, Combined With Bevacizumab and HAI of FOLFOX for Advanced Unresectable Hepatocellular Carcinoma
Phase 2RecruitingSource updated: Sep 25, 2026
USClinicalTrials.gov【Trial record】
Neoadjuvant Nivolumab With CCR2/5-inhibitor or Anti-IL-8) for Non-small Cell Lung Cancer (NSCLC) or Hepatocellular Carcinoma (HCC)
Phase 2Active, not recruitingSource updated: Sep 25, 2026
USClinicalTrials.gov【Trial record】
A Study Evaluating the Efficacy and Safety of Multiple Immunotherapy-Based Treatment Combinations in Patients With Advanced Liver Cancers (Morpheus-Liver)
Phase 1/2RecruitingSource updated: Aug 14, 2026
USClinicalTrials.gov【Trial record】
Assess Efficacy and Safety of Durvalumab Alone or Combined With Bevacizumab in High Risk of Recurrence HCC Patients After Curative Treatment
Phase 3Active, not recruitingSource updated: Aug 14, 2026
OTHERClinicalTrials.gov【Trial record】
Prospective Evaluation of Hepatocellular Carcinoma Surveillance in At-Risk Patients (Screening HCC)
Not yet recruitingSource updated: Aug 14, 2026
USClinicalTrials.gov【Trial record】
Role of Lisinopril in Preventing the Progression of Non-Alcoholic Fatty Liver Disease, RELIEF-NAFLD Study
Phase 2Active, not recruitingSource updated: Aug 14, 2026
USClinicalTrials.gov【Trial record】
Safety Study to Evaluate the Occurrence of EFAD in Pediatric Patients With PNAC Who Require More Than Eight Weeks of Omegaven Treatment
RecruitingSource updated: Aug 14, 2026
USClinicalTrials.gov【Trial record】
Testing the Combination of the Anticancer Drug Durvalumab With Chemotherapy (Gemcitabine and Cisplatin) at Improving Outcomes for High-Risk Resectable Liver Cancer Before Surgery
Phase 2RecruitingSource updated: Aug 14, 2026
USClinicalTrials.gov【Trial record】
A Study to Determine Whether Chemotherapy and Atezolizumab is Better Than Chemotherapy, Bevacizumab and Atezolizumab in Patients With Advanced Liver Cancer
Phase 2Active, not recruitingSource updated: Aug 13, 2026
USClinicalTrials.gov【Trial record】
First in Human Study to Evaluate AZD9793 in Participants With Advanced or Metastatic Solid Tumours
Phase 1/2RecruitingSource updated: Aug 13, 2026
USClinicalTrials.gov【Trial record】
Observational Study Protocol: LIVER-R
RecruitingSource updated: Aug 13, 2026
CNClinicalTrials.gov【Trial record】
PD-1 mRNA LNP Vaccine for Advanced Primary Hepatocellular Carcinoma.
Phase 1RecruitingSource updated: Aug 13, 2026
USClinicalTrials.gov【Trial record】
People With CHC Who Achieved a Sustained Virological Response Following Therapy With Direct Acting Antiviral Agents
Phase 4Active, not recruitingSource updated: Aug 13, 2026
USClinicalTrials.gov【Trial record】
SIRT With Tremelimumab and Durvalumab for Resectable HCC
Phase 1Active, not recruitingSource updated: Aug 13, 2026
USClinicalTrials.gov【Trial record】
Streamlined Resin Y90 Radiation Segmentectomy for Small HCC
Active, not recruitingSource updated: Aug 13, 2026
CNClinicalTrials.gov【Trial record】
YMN-136 Vaccine for Patients With Advanced Hepatobiliary and Pancreatic Malignancies
Phase 1RecruitingSource updated: Aug 13, 2026
CNClinicalTrials.gov【Trial record】
68Ga-SorB PET/CT Imaging in Patients With Solid Tumors
Not applicableRecruitingSource updated: Aug 12, 2026
CNClinicalTrials.gov【Trial record】
Evaluate the Safety and Efficacy of Combination Therapy With SYS6090 Injection for Hepatocellular Carcinoma
Phase 1/2Not yet recruitingSource updated: Aug 12, 2026
USClinicalTrials.gov【Trial record】
Evaluation of Treatment Predictors Reflecting Beta-catenin Activation in Hepatocellular Carcinoma
Phase 2RecruitingSource updated: Aug 12, 2026
USClinicalTrials.gov【Trial record】
Liver Cancer Prevention Randomized Control Trial
Not applicableActive, not recruitingSource updated: Aug 12, 2026
USClinicalTrials.gov【Trial record】
National Liver Cancer Screening Trial
Phase 4RecruitingSource updated: Aug 12, 2026
USClinicalTrials.gov【Trial record】
Neoadjuvant Dupilumab and Toripalimab in MSS CRC Subjects With Resectable Liver Metastases
Phase 1/2RecruitingSource updated: Aug 12, 2026
CNClinicalTrials.gov【Trial record】
Protective Mechanisms of Phycocyanin in Partial Hepatectomy-Associated Liver Injury
Not applicableRecruitingSource updated: Aug 12, 2026
USClinicalTrials.gov【Trial record】
Safety of HRX215 in Patients After Minor and Major Liver Resection
Phase 1/2RecruitingSource updated: Aug 12, 2026
CNClinicalTrials.gov【Trial record】
the Effect of Nutrition-optimized Prehabilitation on Perioperative Intervention in Primary Liver Carcinoma
Not applicableRecruitingSource updated: Aug 12, 2026
USClinicalTrials.gov【Trial record】
A Study of MGC026 in Participants With Advanced Solid Tumors
Phase 1RecruitingSource updated: Aug 11, 2026
OTHERClinicalTrials.gov【Trial record】
CT Volumetry and Hepatic Vascular Deformation Mapping to Predict Post-Hepatectomy Liver Failure
Not yet recruitingSource updated: Aug 11, 2026
USClinicalTrials.gov【Trial record】
HepQuant: Study to Assess the Role of Blood-based Biomarkers and Quantitative MR Imaging for Patients Receiving Radiation Therapy for Liver Cancer
Not applicableRecruitingSource updated: Aug 11, 2026
CNClinicalTrials.gov【Trial record】
Lenvatinib, Sintilimab, and DEB-TACE With/Without HAIC for HCC >7 cm With PVTT
Phase 2RecruitingSource updated: Aug 11, 2026
OTHERClinicalTrials.gov【Trial record】
STRIDE (Durvalumab + Tremelimumab) With Lenvatinib vs STRIDE Alone in Unresectable Hepatocellular Carcinoma
Phase 2RecruitingSource updated: Aug 11, 2026
USClinicalTrials.gov【Trial record】
BAL/BOT/agenT-797 in pMMR CRC With Liver Metastases
Phase 2RecruitingSource updated: Aug 10, 2026
USClinicalTrials.gov【Trial record】
Molecular Basis of Pediatric Liver Cancer
RecruitingSource updated: Aug 10, 2026
CNClinicalTrials.gov【Trial record】
The Safety, Efficacy, and Immune Response of Multimodal Thermal Therapy in the Treatment of Malignant Liver Tumors
Not applicableRecruitingSource updated: Aug 10, 2026
CNClinicalTrials.gov【Trial record】
Toripalimab or Placebo as Adjuvant Therapy in Hepatocellular Carcinoma After Radical Resection
Phase 2/3Active, not recruitingSource updated: Aug 10, 2026
OTHERClinicalTrials.gov【Trial record】
Development and Dissemination of Exercise Prescription and Intervention for Cancer Populations
Not applicableRecruitingSource updated: Aug 7, 2026
USClinicalTrials.gov【Trial record】
A Study to Evaluate ARV-6723 Alone and With Pembrolizumab in Participants With Advanced Solid Tumors
Phase 1/2RecruitingSource updated: Aug 6, 2026
CNClinicalTrials.gov【Trial record】
SHR-1701 Plus Apatinib for Second-Line Treatment in Targeted-Immune Pretreated Advanced Hepatocellular Carcinoma
Phase 2Not yet recruitingSource updated: Aug 6, 2026
CNCDE【Guideline / public regulatory information】
CDE 临床试验默示许可 — clinical trial implied licence notices
Index verified: Aug 16, 2026
CNCDE【Guideline / public regulatory information】
CDE 优先审评公示 — priority review listings
Index verified: Aug 16, 2026
CNCDE【Guideline / public regulatory information】
CDE 受理品种信息 — applications accepted for review
Index verified: Aug 16, 2026
CNCDE【Guideline / public regulatory information】
CDE 指导原则 — published technical guidance documents
Index verified: Aug 16, 2026
CNCDE【Guideline / public regulatory information】
CDE 突破性治疗公示 — breakthrough therapy designation notices
Index verified: Aug 16, 2026
CNCDE【Guideline / public regulatory information】
CDE 附条件批准品种 — conditionally approved products list
Index verified: Aug 16, 2026
CNChiCTR【Guideline / public regulatory information】
ChiCTR — Chinese Clinical Trial Registry, public search
Index verified: Aug 16, 2026
EUCTIS【Guideline / public regulatory information】
CTIS public register — search clinical trials authorised in the EU/EEA
Index verified: Aug 16, 2026
EUEMA【Guideline / public regulatory information】
EMA — CHMP meeting highlights and opinions on new medicines
Index verified: Aug 16, 2026
EUEMA【Guideline / public regulatory information】
EMA — medicines for human use currently under evaluation (monthly CHMP list)
Index verified: Aug 16, 2026
EUEMA【Guideline / public regulatory information】
EMA — searchable database of authorised medicines in the EU
Index verified: Aug 16, 2026
EUESMO【Guideline / public regulatory information】
ESMO Clinical Practice Guidelines — gastrointestinal cancers
Index verified: Aug 16, 2026
EUESMO【Guideline / public regulatory information】
ESMO Clinical Practice Guidelines — public index by tumour type
Index verified: Aug 16, 2026
EUESMO【Guideline / public regulatory information】
ESMO Clinical Practice Guidelines — supportive and palliative care section
Index verified: Aug 16, 2026
USFDA【Guideline / public regulatory information】
FDA — expanded access (compassionate use) information for patients
Index verified: Aug 16, 2026
USFDA【Guideline / public regulatory information】
FDA — oncology (cancer) / hematologic malignancies approval notifications
Index verified: Aug 16, 2026
USFDA【Guideline / public regulatory information】
FDA — ongoing accelerated approvals for oncology indications
Index verified: Aug 16, 2026
USNCCN【Guideline / public regulatory information】
NCCN Guidelines — palliative care category listing
Index verified: Aug 16, 2026
USNCCN【Guideline / public regulatory information】
NCCN Guidelines — public index by cancer type (free registration)
Index verified: Aug 16, 2026
USNCCN【Guideline / public regulatory information】
NCCN Guidelines for Patients — plain-language versions
Index verified: Aug 16, 2026
CNNMPA【Guideline / public regulatory information】
NMPA 药品 — national drug approval announcements
Index verified: Aug 16, 2026
CNCDE【Guideline / public regulatory information】
药物临床试验登记与信息公示平台 — national registry of drug trials conducted in China
Index verified: Aug 16, 2026